The A640G polymorphism in the NAD(P)H oxidase p22phox gene (CYBA) is associated with risk reduction of coronary heart disease: A meta-analysis
Authors:
- 1 April 2014
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 47 (6) , 409-416
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81260594)
- Guangxi National Natural Science Foundation (2013GXNSFAA019145)
- significant scientific research foundation of the Guangxi Health Department (2012047)
This publication has 23 references indexed in Scilit:
- Chitinase 3-like 1 gene-329G/A polymorphism, plasma concentration and risk of coronary heart disease in a Chinese populationGene, 2012
- Secondary prevention strategies for coronary heart diseaseJournal of Thrombosis and Thrombolysis, 2009
- Heart Disease and Stroke Statistics—2009 UpdateCirculation, 2009
- Coronary heart disease in ChinaHeart, 2008
- Major Causes of Death in ChinaNew England Journal of Medicine, 2006
- NAD(P)H Oxidases in Rat Basilar Arterial Endothelial CellsStroke, 2005
- Novel NAD(P)H oxidases in the cardiovascular system: Table 1Heart, 2004
- Nox4 as the Major Catalytic Component of an Endothelial NAD(P)H OxidaseCirculation, 2004
- Vascular NAD(P)H oxidases: specific features, expression, and regulationAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2003
- p22 Is a Critical Component of the Superoxide-generating NADH/NADPH Oxidase System and Regulates Angiotensin IIinduced Hypertrophy in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1996